Home / Research and experimental development on chemicals (except medical and veterinary science)

IMMUNTECH SINGAPORE PTE. LTD.

Live CompanyUEN 202018659GLocal Company

IMMUNTECH SINGAPORE PTE. LTD. is a local company in Singapore with UEN 202018659G. It was registered on 2 Jul 2020, 6 years ago. Its status is Live Company. Its main activity is research and experimental development on chemicals (except medical and veterinary science).

UEN202018659G
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered2 Jul 2020
Main activity (SSIC)72103 Research and experimental development on chemicals (except medical and veterinary science)
Secondary activity46649 Wholesale of chemicals and chemical products n.e.c.
Address22 NEW INDUSTRIAL ROAD, #03-02, PRIMAX, Singapore 536208
208 companies at this address
AreaHougang · District 19 (Serangoon Garden, Hougang, Punggol)
Nearest stationBartley MRT, about 694 m
Officers8
Last annual return27 Nov 2025

Newer companies in research and experimental development on chemicals (except medical and veterinary science)

  • ANVL PTE. LTD.202639992Z · 31 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • BAMCORE TECH PTE. LTD.202639601K · 28 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • PMA NANO CARBON TECHNOLOGY PTE. LTD.202616965H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • SILVERX TECHNOLOGY PTE. LTD.202616838H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • INNATUS THERAPEUTICS PTE. LTD.202616249E · 13 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • ABUNDANCE SPECIALTY CHEMICALS PTE. LTD.202611248M · 13 Mar 2026 · Research and experimental development on chemicals (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.